It's not sad. it's AMBS! What did you expect? This is still a rinky dink start up biotech with absolutely no significant coverage what so ever and a history of Pr disasters and manipulation. It will fly once more pieces of the puzzle are put together. We just don't know when. But the pieces are coming together. The last big piece as I have stated in the past is funding.